The COVID-19 epidemic (Coronavirus Disease 2019) which is currently raging in France is an emerging infectious disease linked to a virus of the genus coronavirus (SARS-CoV-2). The first cases were reported in Wuhan, China, in late December 2019 \[1\]. Globally, it has been placed in the "pandemic" stage by the WHO since March 11, 2020. Coronavirus viruses have been responsible for epidemics in the past such as the SARS epidemic in 2002 (Syndrome Severe Acute Respiratory) linked to the SARS-CoV virus, or the epidemic of MERS (Middle East Respiratory Syndrome) that affected the Middle East in 2012. Patients with chronic lymphocytic leukemia (CLL) / lymphocytic lymphoma or Waldenstrom Disease (WD) therefore represent a population at high risk of developing a severe form in the event of COVID-19 infection. To date, no data is available in the literature to assess the impact of the COVID-19 epidemic in this population of patients with CLL / lymphocytic lymphoma or WD.
Study Type
OBSERVATIONAL
Enrollment
162
Collection of clinical data, treatment regimens and survival data
Chu Angers
Angers, France
CHU Jean Minjoz - Hématologie
Besançon, France
Hôpital Avicenne - Centre de Recherche Clinique
Bobigny, France
CHU Estaing - Hématologie Clinique Adulte
Clermont-Ferrand, France
Chu Creteil
Créteil, France
CHU Grenoble - Hématologie
Grenoble, France
Chd Vendee
La Roche-sur-Yon, France
Centre Hospitalier du Mans
Le Mans, France
Hôpital Saint Vicent de Paul
Lille, France
Centre Léon Bérard - Hématologie
Lyon, France
...and 12 more locations
Prognostic factors for healing of COVID-19 infection
Hematological pathology Description
Time frame: Day 0
Medical care of Coronavirus infection
Describe the management carried out concerning Coronavirus infection and its impact on the treatment of hemopathy.
Time frame: within 12 months after diagnosis
national epidemiological monitoring
Allow national epidemiological monitoring and regularly inform the hematology community.
Time frame: through study completion, an average of 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.